FR2352533B1 - - Google Patents

Info

Publication number
FR2352533B1
FR2352533B1 FR7715965A FR7715965A FR2352533B1 FR 2352533 B1 FR2352533 B1 FR 2352533B1 FR 7715965 A FR7715965 A FR 7715965A FR 7715965 A FR7715965 A FR 7715965A FR 2352533 B1 FR2352533 B1 FR 2352533B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7715965A
Other languages
French (fr)
Other versions
FR2352533A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2352533A1 publication Critical patent/FR2352533A1/fr
Application granted granted Critical
Publication of FR2352533B1 publication Critical patent/FR2352533B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7715965A 1976-05-27 1977-05-25 Procede de detection du cancer Granted FR2352533A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69045476A 1976-05-27 1976-05-27

Publications (2)

Publication Number Publication Date
FR2352533A1 FR2352533A1 (fr) 1977-12-23
FR2352533B1 true FR2352533B1 (ref) 1980-06-13

Family

ID=24772522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7715965A Granted FR2352533A1 (fr) 1976-05-27 1977-05-25 Procede de detection du cancer

Country Status (18)

Country Link
JP (1) JPS52145517A (ref)
AT (1) AT357690B (ref)
AU (1) AU506539B2 (ref)
BE (1) BE855063A (ref)
DE (1) DE2724114A1 (ref)
DK (1) DK233277A (ref)
ES (1) ES459164A1 (ref)
FI (1) FI771646A7 (ref)
FR (1) FR2352533A1 (ref)
GB (1) GB1520208A (ref)
IE (1) IE45284B1 (ref)
IL (1) IL52133A0 (ref)
LU (1) LU77413A1 (ref)
NL (1) NL7705873A (ref)
NO (1) NO771860L (ref)
NZ (1) NZ184159A (ref)
SE (1) SE7706203L (ref)
ZA (1) ZA773026B (ref)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Also Published As

Publication number Publication date
ZA773026B (en) 1978-04-26
IE45284B1 (en) 1982-07-28
ATA376977A (de) 1979-12-15
NO771860L (no) 1977-11-29
BE855063A (fr) 1977-11-28
DE2724114A1 (de) 1977-12-15
AU2534177A (en) 1978-11-23
LU77413A1 (ref) 1978-06-26
NL7705873A (nl) 1977-11-29
DK233277A (da) 1977-11-28
FR2352533A1 (fr) 1977-12-23
AT357690B (de) 1980-07-25
SE7706203L (sv) 1977-11-28
JPS52145517A (en) 1977-12-03
IL52133A0 (en) 1977-07-31
ES459164A1 (es) 1978-04-16
AU506539B2 (en) 1980-01-10
IE45284L (en) 1977-11-27
GB1520208A (en) 1978-08-02
NZ184159A (en) 1979-03-28
FI771646A7 (ref) 1977-11-28

Similar Documents

Publication Publication Date Title
FI770754A7 (ref)
FR2352447B1 (ref)
JPS5636689Y2 (ref)
JPS5639188Y2 (ref)
JPS5334347U (ref)
JPS543219Y2 (ref)
FR2352533B1 (ref)
CS175504B1 (ref)
JPS5340576U (ref)
JPS5381327U (ref)
JPS52164229U (ref)
JPS52133363U (ref)
JPS52117065U (ref)
JPS5389386U (ref)
CS177436B1 (ref)
DD125175A1 (ref)
DD123785A1 (ref)
DD126844A1 (ref)
DD126564A5 (ref)
DD126229A1 (ref)
DD126129A1 (ref)
DD125885A1 (ref)
DD125844A1 (ref)
DD125757A1 (ref)
DD125730A1 (ref)

Legal Events

Date Code Title Description
ST Notification of lapse